Arcutis Biotherapeutics
ARQT · NASDAQ
Who owns ARQT
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 55.5% of ARQT’s shares.
- Montanova Capital, LLC9.9%
- Frazier Life Sciences Management, L.P.7.9%
- BlackRock Institutional Trust Company, N.A.7.1%
- Rubric Capital Management LP6.6%
- Next 6 largest institutions23.9%
- All other shareholders44.5%
| Holder | Shares | % of shares |
|---|---|---|
| Montanova Capital, LLC | 12.44M | 9.94% |
| Frazier Life Sciences Management, L.P. | 9.87M | 7.89% |
| BlackRock Institutional Trust Company, N.A. | 8.93M | 7.14% |
| Rubric Capital Management LP | 8.27M | 6.61% |
| Polar Capital LLP | 6.61M | 5.28% |
| State Street Investment Management (US) | 5.82M | 4.66% |
| Vanguard Capital Management, LLC | 4.99M | 3.99% |
| Morgan Stanley & Co. LLC | 4.26M | 3.40% |
| Jennison Associates LLC | 4.22M | 3.37% |
| D. E. Shaw & Co., L.P. | 3.95M | 3.16% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Polar Capital Biotechnology Fund | 6.26M | 5.00% |
| Vanguard Total Stock Market Index Fund | 3.58M | 2.86% |
| State Street SPDR S&P Biotech ETF | 3.07M | 2.45% |
| iShares Russell 2000 ETF | 2.93M | 2.35% |
| American Century Small Cap Growth Fund | 1.47M | 1.17% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders sold $2.80M (22 trades) of ARQT on the open market, with no buys.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Matsuda Masaru | Sale | 3.67K | $91.85K |
| Welgus Howard G. | Option exercise | 2.25K | — |
| Welgus Howard G. | Option exercise | 1.02K | — |
| Welgus Howard G. | Option exercise | 822 | — |
| Welgus Howard G. | Sale | 4.73K | $114.37K |
| Welgus Howard G. | Option exercise | 2.25K | $19.46K |
| Welgus Howard G. | Option exercise | 1.02K | $7.65K |
| Welgus Howard G. | Option exercise | 822 | $5.36K |
| Matsuda Masaru | Sale | 9.99K | $249.99K |
| Curran Terrie | Option exercise | 27.05K | — |
Congressional trades
Disclosed by members of Congress over the last 12 months
| Member | Type | Amount | Traded |
|---|---|---|---|
| Gil CisnerosHouse | Purchase | $1K–$15K | Mar 3, 2026 |
| Gil CisnerosHouse | Sale | $1K–$15K | Dec 11, 2025 |
Short interest
Settled Sep 30, 2026
- Shares short
- 21.69M
- Days to cover
- 4.83
- % of shares outstanding
- 17.34%
- Average daily volume
- 4.49M
- Change since last report
- +17.5%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.